Julie Rubinstein

Julie Rubinstein has extensive experience in the biotechnology and healthcare industries, currently serving as a Board Member at Gift of Life Biologics and Vice Chair of the Board of Directors at The Valerie Fund. Julie has held various leadership roles at Adaptive Biotechnologies Corp. since 2011, including President and Chief Operating Officer, as well as Chief Business Officer and Senior Vice President of Corporate and Business Development. Previous experience includes a position as Senior Director of Worldwide Commercial Development for Oncology Products at Pfizer, along with multiple roles in commercial development and business development within Pfizer Pharmaceuticals. Additionally, Julie has experience as Market Development Manager at Johnson & Johnson, and in marketing and business development at Collegiate Health Care. Julie began a career as a Financial Analyst in Morgan Stanley's Healthcare Group. Julie holds an MBA from Harvard Business School, a BA in Communications with a French minor from the University of Pennsylvania, and a BSE in International Management from The Wharton School.